StonvexLoading…
StonvexStonvexStonvexCore line items from USFD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $9.61B | $39.42B | $29.62B | $19.43B |
Operating Income | $216.00M | $1.20B | $878.00M | $596.00M |
Net Income | $116.00M | $676.00M | $492.00M | $224.00M |
EPS (Diluted) | $0.52 | $2.94 | $2.12 | $1.45 |
Total Assets | $14.16B | $13.94B | $14.04B | $13.79B |
Total Liabilities | $9.83B | $9.64B | $9.57B | $9.16B |
Cash & Equivalents | $49.00M | $41.00M | $56.00M | $61.00M |
Free Cash Flow OCF − CapEx | $196.00M | $959.00M | $800.00M | $564.00M |
Shares Outstanding | 220.40M | 220.50M | 224.60M | 228.50M |